Summary
This 8-K filing by HCA Healthcare, Inc. (HCA) on May 1, 2018, primarily details changes to the compensation program for non-management directors and reports on the outcomes of the company's Annual Meeting of Stockholders held on April 26, 2018. The revised director compensation program introduces a combination of cash retainers for board service and committee roles, along with annual equity awards in the form of restricted stock units. This move aims to align director interests with those of shareholders through increased equity ownership requirements. The filing also confirms the overwhelming approval of key proposals at the annual meeting, including the election of all eleven director nominees, the ratification of Ernst & Young LLP as the independent auditor, and advisory approval of executive compensation. Importantly, stockholders also approved holding "say-on-pay" advisory votes on executive compensation on an annual basis, signaling a preference for more frequent shareholder input on executive remuneration.
Key Highlights
- 1HCA Healthcare revised its non-management director compensation program, effective April 26, 2018.
- 2The new program includes annual cash retainers for board service ($110,000) and committee roles, as well as committee chair positions.
- 3Non-management directors will receive an annual board equity award valued at $175,000, consisting of restricted stock units that vest on the first anniversary of the grant date or at the next annual meeting.
- 4Directors are now required to acquire company stock valued at five times their annual cash retainer within three years.
- 5All eleven nominated directors were overwhelmingly elected to the Board of Directors at the April 26, 2018 Annual Meeting.
- 6Shareholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for 2018.
- 7The company's "say-on-pay" advisory vote on executive compensation was approved, and shareholders voted for this vote to be held annually.